As the level of PNPLA3 expression in humans is variable, it is conceivable that inter-individual differences in PNPLA3 gene expression further modify the risk for NAFLD attributed to the 148M variant. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.